companies

CurifyLabs

Founded 2021
Employees 15+
Primary contact
Salmisaarenaukio 1
00180 Helsinki
Finland
+358 (0) 400 188 781
Links
https://www.curifylabs.com/
Sections
Technologies
CurifyLabs is offering a new innovative approach to compounding. It has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on-site in pharmacies. CurifyLabs' offering brings industry-level standards to the mass customization of medicines and the impact of CurifyLabs technology is better patient safety and efficacy at significantly lower cost. The company is able to offer a more cost-effective and flexible solution to manual compounding, and today CurifyLabs serves pharmacies on several European markets. The technology is based on over 10 years of academic research conducted by Professor Niklas Sandler Topelius.
Founded 2021
Employees 15+
Primary contact
Salmisaarenaukio 1
00180 Helsinki
Finland
+358 (0) 400 188 781
Links
https://www.curifylabs.com/
Sections
Technologies

Funding 💰

Total $3.5M
Select investors Lifeline Ventures, European Innovation Council, Apteekkien Eläkekassa, Avohoidon Tutkimussäätiö

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solving the problem: Age, gender, lifestyle, genetic and metabolic differences all affect the way patients respond to therapies. Standardized dosing and therapies can lead to poor treatment efficacy, undesirable side effects and adherence issues, particularly in pediatrics and oncology. Practical manufacturing methods are needed for these personalized medicines and the MiniLab technology automates what has been a largely manual process, allowing for a significant reduction in complexity and time.
  • Proprietary tech: The MiniLab is a unique and proprietary manufacturing solution, which enables tailored 3D printing of bespoke pharmaceuticals by compounding pharmacies. It has been designed to support compounding pharmacies in eliminating the laborious and time-consuming manual manufacturing of pharmaceuticals and delivering tailored medicines with robust quality control at the point-of-care.
  • Eyes on Europe: The MiniLab is already successfully piloted by several innovative pharmacies in multiple European markets including Finland, Spain, Switzerland, Germany and the Netherlands.

Video ▶️

Last update: May 23, 2023